Hematology and Flow Cytometry in Europe: Market Segment Forecasts and Supplier Shares

March 2013 | 450 pages | ID: HC4E9EEB0AFEN
Venture Planning Group

Abstracts

This unique report provides information not available from any other published source, including test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers:

• Specimen forecasts by market segment
• Test volume forecasts by assay and market segment
• Reagent and instrument sales forecasts by market segment
• Instrument placements and installed base by manufacturer and model
• Sales and market shares of reagent and instrument suppliers

This report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next five years. The report explores future marketing and technological trends in five major European countries (France, Germany, Italy, Spain, UK); provides market share estimates, test volume forecasts, and instrument placements; compares features of leading analyzers; profiles of top competitors and emerging market entrants; and suggests specific product and marketing opportunities for instrument and reagent suppliers.

During the next five years, the continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunological forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of innovative self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.

Contains 450 pages and 190 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. MAJOR ROUTINE AND SPECIAL HEMATOLOGY TESTS

1. Introduction
2. CBC Analysis
  a. Hemoglobin Concentration
  b. Hematocrit Determination
  c. Red Blood Cell Count
  d. Red Cell Indices
    MCV
    RDW
    MCHC
    CHCM
    HDW
    MCH
  e. Red Cell Size Histograms
  f. Platelets
    Platelet Count
    Platelet Size/MPV
    PDW
    Automated Systems
  g. Reticulocytes
3. White Blood Cell Analysis
  a. WBC Count
  b. Five-Partial Differential Major Suppliers
    Abbott
    Beckman Coulter/Danaher
    Siemens
    Sysmex
  c. Pattern Recognition Systems
    IRIS
  d. Comparison of Major Differential Analyzers
4. Reticulocytes
5. Platelet Function Tests
6. Erythrocyte Sedimentation Rate/CRP
7. Red Cell Analysis
8. 2, 3 DPG
9. Red Cell Deformability
10. Neutrophil Function Tests
11. Semen Analysis
12. Bone Marrow Analysis
13. Urinalysis

B. MAJOR FLOW CYTOMETRY APPLICATIONS

1. Cell Surface Markers
  a. Lymphocyte Subclassification CD4/CD8
    Instrumentation and Reagent Test Kits
      BD
      Beckman Coulter/Danaher
      T Cells Diagnostics
  b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Chromosome Analysis
7. Fetal Cell Analysis
8. HLA Typing
9. Microbiology
10. Protein Content Analysis
11. Multiparameter Analysis
12. Other Applications

C. INSTRUMENTATION REVIEW

1. Hematology Analyzers
  a. Overview
    Electrical Aperture-Impedance Analyzers
    Light Scatter Analyzers
  b. System Review
    Abbott
    Beckman Coulter/Danaher
    Biocode Hycel